drugset / Trial / NCT05493228

Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

NCT05493228

Phase 3 Unknown 38 enrolled Children's Cancer Hospital Egypt 57357
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this trial is to investigate whether the effect of a low-dose dexmedetomidine infusion will decrease propofol consumption or not through a double blinded randomized controlled trial done in children cancer hospital 57357.

Timeline

Start
2022-05-17
Primary completion
2023-04-17
Completion
2023-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications